Notogen (@NotogenInc) header
Notogen (@NotogenInc) profile picture

Notogen is biotechnology company developing regenerative therapeutics for conditions related to spinal degeneration, orthopedics and sports medicine.

Toronto, Canada
Joined November 2018
Photo by Notogen (@NotogenInc)Photo by Notogen (@NotogenInc)
Notogen is very pleased to announce that it has entered a worldwide research collaboration and license agreement with Boehringer Ingelheim to develop and commercialize a Notogen regenerative therapeutic for people living with degenerative disc disease. einpresswire.com/article/607…
1
1
2
108
New CEO, Gary Margolis, believes NTG-101 "has the potential to be a game-changing treatment for disc degeneration disease.” ow.ly/2JDw30mJlqX
1
1
"The findings are supportive of NTG-101 as a means to impede disc degeneration, promote disc regeneration, halt inflammation, and suppress the expression of molecules secreted by discs that are known causes of pain.” -Dr. Mark Erwin #biotech #regenerativemedicine
NTG-101: A Novel Molecular Therapy that Halts the Progression of Degenerative Disc Disease ow.ly/wlyD30mCpL8 @SciReports @UofT @UAlberta @UHN
Therapeutic Potential of NTG-101, a Single Dose Injectable Treatment for Degenerative Disc Disease, Demonstrated in Preclinical Large Animal Study Published in Nature Publishing Group's “Scientific Reports” ow.ly/fZBy30mCrFL @SciReports @NatureNews
1
1
We're pleased to announce the launch of our new website. Visit us at notogen.com #biotech #startup #regenerativemedicine
1
1